Related references
Note: Only part of the references are listed.Nicotinic receptors regulate the dynamic range of dopamine release in vivo
Jessica L. Koranda et al.
JOURNAL OF NEUROPHYSIOLOGY (2014)
Randomized trial of nicotine replacement therapy (NRT), bupropion and NRT plus bupropion for smoking cessation: effectiveness in clinical practice
John Stapleton et al.
ADDICTION (2013)
Effect of a Nicotine Vaccine on Nicotine Binding to β2*-Nicotinic Acetylcholine Receptors In Vivo in Human Tobacco Smokers
Irina Esterlis et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Unraveling the neurobiology of nicotine dependence using genetically engineered mice
Astrid K Stoker et al.
CURRENT OPINION IN NEUROBIOLOGY (2013)
Effects of bupropion on cognitive performance during initial tobacco abstinence
Kenneth A. Perkins et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
Neuropsychiatric Adverse Events of Varenicline A Systematic Review of Published Reports
Amir I. A. Ahmed et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
PET Imaging of High-Affinity α4β2 Nicotinic Acetylcholine Receptors in Humans with 18F-AZAN, a Radioligand with Optimal Brain Kinetics
Dean F. Wong et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Divergent Functional Effects of Sazetidine-A and Varenicline During Nicotine Withdrawal
Jill R. Turner et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Effects of Varenicline on Abstinence and Smoking Reward Following a Programmed Lapse
Erin A. McClure et al.
NICOTINE & TOBACCO RESEARCH (2013)
Effect of Varenicline on Individual Nicotine Withdrawal Symptoms: A Combined Analysis of Eight Randomized, Placebo-Controlled Trials
Jonathan Foulds et al.
NICOTINE & TOBACCO RESEARCH (2013)
Influence of CYP2B6 genetic variants on plasma and urine concentrations of bupropion and metabolites at steady state
Neal L. Benowitz et al.
PHARMACOGENETICS AND GENOMICS (2013)
Genetic background influences the effects of withdrawal from chronic nicotine on learning and high-affinity nicotinic acetylcholine receptor binding in the dorsal and ventral hippocampus
Derek S. Wilkinson et al.
PSYCHOPHARMACOLOGY (2013)
Effects of nicotine withdrawal on cognition in a clinical trial setting
Keith A. Wesnes et al.
PSYCHOPHARMACOLOGY (2013)
Cigarette craving and withdrawal symptoms during temporary abstinence and the effect of nicotine gum
Jamie Brown et al.
PSYCHOPHARMACOLOGY (2013)
Role of α5*nicotinic acetylcholine receptors in the effects of acute and chronic nicotine treatment on brain reward function in mice
Christie D. Fowler et al.
PSYCHOPHARMACOLOGY (2013)
A fresh look at tobacco harm reduction: the case for the electronic cigarette
Riccardo Polosa et al.
HARM REDUCTION JOURNAL (2013)
Electronic cigarettes: achieving a balanced perspective
Theodore L. Wagener et al.
ADDICTION (2012)
Withdrawal from Chronic Nicotine Exposure Alters Dopamine Signaling Dynamics in the Nucleus Accumbens
Lifen Zhang et al.
BIOLOGICAL PSYCHIATRY (2012)
The efficacy and safety of a nicotine conjugate vaccine (NicVAX®) or placebo co-administered with varenicline (Champix®) for smoking cessation: study protocol of a phase IIb, double blind, randomized, placebo controlled trial
Philippe H. J. Hoogsteder et al.
BMC PUBLIC HEALTH (2012)
CYP2B6 and Bupropion's Smoking-Cessation Pharmacology: The Role of Hydroxybupropion
A. Z. X. Zhu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Nicotine Vaccines to Assist with Smoking Cessation
Tobias Raupach et al.
DRUGS (2012)
Selective re-expression of β2 nicotinic acetylcholine receptor subunits in the ventral tegmental area of the mouse restores intravenous nicotine self-administration
Maria Juliana Orejarena et al.
NEUROPHARMACOLOGY (2012)
The duration of nicotine withdrawal-associated deficits in contextual fear conditioning parallels changes in hippocampal high affinity nicotinic acetylcholine receptor upregulation
Thomas J. Gould et al.
NEUROPHARMACOLOGY (2012)
AT-1001: A High Affinity and Selective α3β4 Nicotinic Acetylcholine Receptor Antagonist Blocks Nicotine Self-Administration in Rats
Lawrence Toll et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Effects of the specific α4β2 nAChR antagonist, 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine, on nicotine reward-related behaviors in rats and mice
K. M. Tobey et al.
PSYCHOPHARMACOLOGY (2012)
Nicotine control: E-cigarettes, smoking and addiction
Kirsten Bell et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2012)
Reward, Addiction, Withdrawal to Nicotine
Mariella De Biasi et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 34 (2011)
Vaccination against nicotine alters the distribution of nicotine delivered via cigarette smoke inhalation to rats
M. Pravetoni et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Nicotinic acetylcholine receptor-mediated mechanisms in lung cancer
Ma Reina Improgo et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study
Riccardo Polosa et al.
BMC PUBLIC HEALTH (2011)
The Efficacy and Tolerability of Bupropion in the Treatment of Major Depressive Disorder
Ricardo Moreira
CLINICAL DRUG INVESTIGATION (2011)
Immunogenicity and Smoking-Cessation Outcomes for a Novel Nicotine Immunotherapeutic
D. K. Hatsukami et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Electrophysiological Perspectives on the Therapeutic Use of Nicotinic Acetylcholine Receptor Partial Agonists
Roger L. Papke et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
E-Cigarette or Drug-Delivery Device? Regulating Novel Nicotine Products
Nathan K. Cobb et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The effects of acute, chronic, and withdrawal from chronic nicotine on novel and spatial object recognition in male C57BL/6J mice
Justin W. Kenney et al.
PSYCHOPHARMACOLOGY (2011)
Electronic cigarettes: a new 'tobacco' industry?
Jonathan K. Noel et al.
TOBACCO CONTROL (2011)
Novel Nicotine Delivery Systems and Public Health: The Rise of the E-Cigarette
Nathan K. Cobb et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2010)
Effects of the α4β2 Partial Agonist Varenicline on Brain Activity and Working Memory in Abstinent Smokers
James Loughead et al.
BIOLOGICAL PSYCHIATRY (2010)
Working memory deficits predict short-term smoking resumption following brief abstinence
Freda Patterson et al.
DRUG AND ALCOHOL DEPENDENCE (2010)
Effects of Hydroxymetabolites of Bupropion on Nicotine Dependence Behavior in Mice
M. Imad Damaj et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Nicotine addiction and nicotinic receptors: lessons from genetically modified mice
Jean-Pierre Changeux
NATURE REVIEWS NEUROSCIENCE (2010)
Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats
Grazyna Biala et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2010)
Effect of the α4β2*nicotinic acetylcholine receptor partial agonist varenicline on dopamine release in β2 knock-out mice with selective re-expression of the β2 subunit in the ventral tegmental area
Christelle Reperant et al.
NEUROPHARMACOLOGY (2010)
Neurocircuitry of Addiction
George F. Koob et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial
C. Bullen et al.
TOBACCO CONTROL (2010)
Convergence of genetic findings for nicotine dependence and smoking related diseases with chromosome 15q24-25
Laura Jean Bierut
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
β2-Nicotinic Acetylcholine Receptor Availability During Acute and Prolonged Abstinence From Tobacco Smoking
Kelly P. Cosgrove et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Incidental (unreinforced) and reinforced spatial learning in rats with ventral and dorsal lesions of the hippocampus
Stephane Gaskin et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Nicotinic acetylcholine receptors and the ascending dopamine pathways
Phil D. Livingstone et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Varenicline Improves Mood and Cognition During Smoking Abstinence
Freda Patterson et al.
BIOLOGICAL PSYCHIATRY (2009)
Nicotine withdrawal-induced deficits in trace fear conditioning in C57BL/6 mice - a role for high-affinity beta 2 subunit-containing nicotinic acetylcholine receptors
J. D. Raybuck et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Hippocampal nAChRs mediate nicotine withdrawal-related learning deficits
Jennifer A. Davis et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)
Nicotine Dependence Pharmacogenetics: Role of Genetic Variation in Nicotine-Metabolizing Enzymes
Riju Ray et al.
JOURNAL OF NEUROGENETICS (2009)
Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of α4β2 nicotinic receptors in rats
Krista Spiller et al.
NEUROPHARMACOLOGY (2009)
Varenicline for smoking cessation: A placebo-controlled, randomized study
Chen Wang et al.
RESPIROLOGY (2009)
Is cancer triggered by altered signalling of nicotinic acetylcholine receptors?
Hildegard M. Schuller
NATURE REVIEWS CANCER (2009)
Efficacy and safety of varenicline for smoking cessation
J. Taylor Hays et al.
AMERICAN JOURNAL OF MEDICINE (2008)
Varenicline Ameliorates Nicotine Withdrawal-Induced Learning Deficits in C57BL/6 Mice
Jonathan D. Raybuck et al.
BEHAVIORAL NEUROSCIENCE (2008)
Crucial Role of α4 and α6 Nicotinic Acetylcholine Receptor Subunits from Ventral Tegmental Area in Systemic Nicotine Self-Administration
S. Pons et al.
JOURNAL OF NEUROSCIENCE (2008)
Greater Nicotinic Acetylcholine Receptor Density in Smokers Than in Nonsmokers: A PET Study with 2-18F-FA-85380
Alexey G. Mukhin et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs
K. J. Jackson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
β2 subunit containing acetylcholine receptors mediate nicotine withdrawal deficits in the acquisition of contextual fear conditioning
George S. Portugal et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2008)
Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice
Astrid K. Stoker et al.
NEUROPHARMACOLOGY (2008)
Chronic bupropion differentially alters the reinforcing, reward-enhancing and conditioned motivational properties of nicotine in rats
Neil E. Paterson et al.
NICOTINE & TOBACCO RESEARCH (2008)
Decreased brain reward function during nicotine withdrawal in C57BL6 mice: Evidence from intracranial self-stimulation (ICSS) studies
Paul M. Johnson et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray
Carol S. Myers et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Bupropion dose-dependently reverses nicotine withdrawal deficits in contextual fear conditioning
George S. Portugal et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2007)
Temporal change in human nicotinic acetylcholine receptor after smoking cessation: 5IA SPECT study
Marcelo Mamedel et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Chronic nicotine administration improves attention while nicotine withdrawal induces performance deficits in the 5-choice serial reaction time task in rats
Svetlana Semenova et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2007)
Rationale, pharmacology and clinical efficacy of partial agonists of α4β2 nACh receptors for smoking cessation
Hans Rollema et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell
Neil E. Paterson et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Atomoxetine reverses nicotine withdrawal-associated deficits in contextual fear conditioning
Jennifer A. Davis et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Effects of abstinence from tobacco: Valid symptoms and time course
John R. Hughes
NICOTINE & TOBACCO RESEARCH (2007)
Nicotine and hippocampus-dependent learning - Implications for addiction
Thomas J. Gould
MOLECULAR NEUROBIOLOGY (2006)
Varenicline is a partial agonist at α4β2 and a full agonist at α7 neuronal nicotinic receptors
Karla B. Mihalak et al.
MOLECULAR PHARMACOLOGY (2006)
Human tobacco smokers in early abstinence have higher levels of β2* nicotinic acetylcholine receptors than nonsmokers
Julie K. Staley et al.
JOURNAL OF NEUROSCIENCE (2006)
Smoking cessation with varenicline, a selective α4β2 nicotinic receptor partial agonist -: Results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up
Mitchell Nides et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation
Cheryl Oncken et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Cigarette smoking saturates brain α4β2 nicotinic acetylcholine receptors
Arthur L. Brody et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
The early time course of smoking withdrawal effects
Peter S. Hendricks et al.
PSYCHOPHARMACOLOGY (2006)
Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation -: A randomized controlled trial
David Gonzales et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation -: A randomized controlled trial
Douglas E. Jorenby et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Working memory in cigarette smokers: Comparison to non-smokers and effects of abstinence
Adnanna Mendrek et al.
ADDICTIVE BEHAVIORS (2006)
The β2 but not α7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice
CL Walters et al.
PSYCHOPHARMACOLOGY (2006)
Reduction of abstinence-induced withdrawal and craving using high-dose nicotine replacement therapy
S Shiffman et al.
PSYCHOPHARMACOLOGY (2006)
Deletion of the beta 2 nicotinic acetylcholine receptor subunit alters development of tolerance to nicotine and eliminates receptor upregulation
S McCallum et al.
PSYCHOPHARMACOLOGY (2006)
Nicotine place preference in the mouse: influences of prior handling, dose and strain and attenuation by nicotinic receptor antagonists
SD Grabus et al.
PSYCHOPHARMACOLOGY (2006)
Brain nicotinic acetylcholine receptors: native subtypes and their relevance
Cecilia Gotti et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Withdrawal from chronic nicotine administration impairs contextual fear conditioning in C57BL/6 mice
JA Davis et al.
JOURNAL OF NEUROSCIENCE (2005)
Brain activity in cigarette smokers performing a working memory task: Effect of smoking abstinence
JS Xu et al.
BIOLOGICAL PSYCHIATRY (2005)
Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors
U Maskos et al.
NATURE (2005)
Desensitization of nicotinic ACh receptors: shaping cholinergic signaling
R Giniatullin et al.
TRENDS IN NEUROSCIENCES (2005)
Varenicline:: An α4β2 nicotinic receptor partial agonist for smoking cessation
JW Coe et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Deficits in a sustained attention task following nicotine withdrawal in rats
M Shoaib et al.
PSYCHOPHARMACOLOGY (2005)
Dopamine and drug addiction: the nucleus accumbens shell connection
G Di Chiara et al.
NEUROPHARMACOLOGY (2004)
Decreased signs of nicotine withdrawal in mice null for the β4 nicotinic acetylcholine receptor subunit
R Salas et al.
JOURNAL OF NEUROSCIENCE (2004)
Motivational influences on cigarette smoking
TB Baker et al.
ANNUAL REVIEW OF PSYCHOLOGY (2004)
Characterization of spontaneous and precipitated nicotine withdrawal in the mouse
MI Damaj et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission
SB Floresco et al.
NATURE NEUROSCIENCE (2003)
A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation
P Tonnesen et al.
JOURNAL OF INTERNAL MEDICINE (2003)
Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat
JF Cryan et al.
PSYCHOPHARMACOLOGY (2003)
Review of bupropion for smoking cessation
R Richmond et al.
DRUG AND ALCOHOL REVIEW (2003)
Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors
ME Nelson et al.
MOLECULAR PHARMACOLOGY (2003)
Subtype-selective up-regulation by chronic nicotine of high-affinity nicotinic receptors in rat brain demonstrated by receptor autoradiography
HN Nguyen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
The diversity of subunit composition in nAChRs:: Evolutionary origins, physiologic and pharmacologic consequences
N Le Novère et al.
JOURNAL OF NEUROBIOLOGY (2002)
Comparative pharmacology of rat and human α7 nAChR conducted with net charge analysis
RL Papke et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Cardiovascular effects of nasal and transdermal nicotine and cigarette smoking
NL Benowitz et al.
HYPERTENSION (2002)
Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats
SXM Li et al.
NEUROPHARMACOLOGY (2002)
Effect of nicotine on brain activation during performance of a working memory task
M Ernst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Desensitization of neuronal nicotinic acetylcholine receptors conferred by N-terminal segments of the β2 subunit
S Bohler et al.
BIOCHEMISTRY (2001)
In vivo imaging of nicotinic receptor upregulation following chronic (-)-nicotine treatment in baboon using SPECT
M Kassiou et al.
NUCLEAR MEDICINE AND BIOLOGY (2001)
Development of ligands for in vivo imaging of cerebral nicotinic receptors
W Sihver et al.
BEHAVIOURAL BRAIN RESEARCH (2000)
Nicotine blood levels and subjective craving for cigarettes
ME Jarvik et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2000)
The effect of bupropion on nicotine craving and withdrawal
S Shiffman et al.
PSYCHOPHARMACOLOGY (2000)
Share Paper
